Skip to main content
SpringerLink
Log in

Folsäure als Sekundärprophylaxe bei kardiovaskulären Erkrankungen

Metaanalyse randomisierter, kontrollierter Studien

Folic acid as secondary prophylaxis in cardiovascular diseases

A meta-analysis of randomized controlled trials

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. B-Vitamin Treatment Trialists‘ Collaboration (2006) Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 151: 282–287

    Article  Google Scholar 

  2. Bazzano LA, Reynolds K, Holder KN, He J (2006) Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 296: 2720–2726

    Article  PubMed  CAS  Google Scholar 

  3. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274: 1049–1057

    Article  PubMed  CAS  Google Scholar 

  4. Dentali F, Gianni M, Ageno W (2007) Folic acid supplementation and cardiovascular diseases. JAMA 297: 1549–1550; author reply 1550

    Article  PubMed  CAS  Google Scholar 

  5. Lange H, Suryapranata H, De Luca G et al. (2004) Folate therapy and in-stent restenosis after coronary stenting. New Engl J Med 350: 2673–2681

    Article  PubMed  CAS  Google Scholar 

  6. McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56: 111–128

    PubMed  CAS  Google Scholar 

  7. Schnyder G, Roffi M, Pin R et al. (2001) Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. New Engl J Med 345: 1593–1600

    Article  PubMed  CAS  Google Scholar 

  8. Toole JF, Malinow MR, Chambless LE et al. (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291: 565–575

    Article  PubMed  CAS  Google Scholar 

  9. Yang Q, Botto LD, Erickson JD et al. (2006) Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 113: 1335–1343

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Keine Angaben.

Author information

Authors and Affiliations

  1. Center for Cardiovascular Research (CCR), Institut für Pharmakologie, Charité Campus Mitte, Universitätsmedizin Berlin, Hessische Straße 3–4, 10115, Berlin, Deutschland

    K. Kappert

Authors
  1. K. Kappert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Kappert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kappert, K. Folsäure als Sekundärprophylaxe bei kardiovaskulären Erkrankungen. Kardiologe 1, 120–122 (2007). https://doi.org/10.1007/s12181-007-0011-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-007-0011-7

Search

Navigation